Psychological consequences of segregation resulting from chronic Burkholderia cepacia infection in adults with CF

Duff, A.J.A.
September 2002
Thorax;Sep2002, Vol. 57 Issue 9, p756
Academic Journal
Background: A group of patients who harbour the same highly transmissible strain of Pseudomonas aeruginosa were identified at a cystic fibrosis (CF) centre. Isolates of this strain display a number of unusual phenotypic features including resistance to most typical antipseudomonal antibiotics. A study was undertaken to see if there was a difference in treatment requirements between CF patients with chronic infection with their own unique P aeruginosa strains (group 1 ) and those who harbour a highly transmissible strain (group 2). Methods: Data on treatment requirements for the year 2000 were collected from the case records of CF patients with chronic P aeruginosa infection who had received inpatient treatment. Patients co-infected with Burkholderia cepacia or other highly transmissible strains of P aeruginosa were excluded. Results: There were 2/56 and 3/22 deaths in groups 1 and 2, respectively; these patients were excluded from the analysis. No difference was found between the two groups for mean age, % predicted forced expiratory volume in 1 second (FEV[sub 1]), % predicted forced vital capacity (FVC), and body mass index. Patients in group 2 had a greater median (range) number of intravenous antibiotic days (60 (17-216) v 33 (4-237) days; p=0.01), inpatient days (39 (7-183) v 16 (1-172) days; p<0.01), and inpatient episodes (3 (1-9) v 2 (1-6); p<0.01), and more respiratory exacerbations (mean (SD) 8.2 (3.4) v6.1 (3.2); p=0.01). Conclusions: Patients who harbour the highly transmissible P aeruginosa strain have a greater treatment burden than patients with CF who harbour their own unique strains. These findings support the need for microbiological surveillance for highly transmissible P aeruginosa and the implementation of infection control measures to prevent cross infection.


Related Articles

  • 2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung. Scott-Thomas, Amy J.; Syhre, Mona; Pattemore, Philip K.; Epton, Michael; Laing, Richard; Pearson, John; Chambers, Stephen T. // BMC Pulmonary Medicine;2010, Vol. 10, p56 

    Background: Pseudomonas aeruginosa infections are associated with progressive life threatening decline of lung function in cystic fibrosis sufferers. Growth of Ps. aeruginosa releases a "grape-like" odour that has been identified as the microbial volatile organic compound 2-aminoacetophenone...

  • Identification of Small Molecule Inhibitors of Pseudomonas aeruginosa Exoenzyme S Using a Yeast Phenotypic Screen. Arnoldo, Anthony; Curak, Jasna; Kittanakom, Saranya; Chevelev, Igor; Lee, Vincent T.; Sahebol-Amri, Mehdi; Koscik, Becky; Ljuma, Lana; Roy, Peter J.; Bedalov, Antonio; Giaever, Guri; Nislow, Corey; Merrill, Rod A.; Lory, Stephen; Stagljar, Igor // PLoS Genetics;Feb2008, Vol. 4 Issue 2, p1 

    Pseudomonas aeruginosa is an opportunistic human pathogen that is a key factor in the mortality of cystic fibrosis patients, and infection represents an increased threat for human health worldwide. Because resistance of Pseudomonas aeruginosa to antibiotics is increasing, new inhibitors of...

  • Organisms isolated from adults with Cystic Fibrosis. McManus, Terence E.; McDowell, Andrew; Moore, John E.; Elborn, Stuart J. // Annals of Clinical Microbiology & Antimicrobials;2004, Vol. 3, p26 

    Background: Patients with cystic fibrosis [CF] have frequent pulmonary exacerbations associated with the isolation of bacterial organisms from sputum samples. It is not clear however, if there are differences in the types of additional organisms isolated from patients who are infected with...

  • Therapeutic Flexible Bronchoscopy in Child with Cystic Fibrosis. Selimovic, Amina; Mujicic, Ermina // Acta Informatica Medica;2006, Vol. 14 Issue 1, p32 

    The report deals with the case of a 10-year-old girl with chronic cystic fibrosis. She has been repeatedly treated at the hospital. She has been hospitalized due to respiratory deterioration. Cystic fibrosis is a rare disease, inherited autosomaly recessively, but is very complex in terms of...

  • Cross infection of cystic fibrosis patients with Pseudomonas aeruginosa. Pitt, T.L. // Thorax;Nov2002, Vol. 57 Issue 11, p921 

    Editorial. Focuses on cross infection of cystic fibrosis (CF) patients with Pseudomonas aeruginosa. Mortality rate of CF patients; Choice of antimicrobial compounds; Drug resistance.

  • P. aeruginosa identified in patients with cystic fibrosis. DeNyse, Ashley; Henry, Jennifer // Infectious Disease News;Dec2010, Vol. 23 Issue 12, p24 

    The article reports on a study which identified Pseudomonas aeruginosa in patients with cystic fibrosis in Canada and Great Britain.

  • Pseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatment. Ferreira da Silva Filho, Luiz Vicente Ribeiro; de Aguiar Ferreira, Flavia; Caldeira Reis, Francisco José; Amorim de Britto, Murilo Carlos; Levy, Carlos Emilio; Clark, Otavio; Dirceu Ribeiro, José // Jornal Brasileiro de Pneumologia;jul/ago2013, Vol. 39 Issue 4, p495 

    Evidence-based techniques have been increasingly used in the creation of clinical guidelines and the development of recommendations for medical practice. The use of levels of evidence allows the reader to identify the quality of scientific information that supports the recommendations made by...

  • Don't Overlook Airborne Pathogens in CF Infection Transmission. Abma, Rebecca K. // Pulmonary Reviews;Dec2009, Vol. 14 Issue 12, p8 

    The article explains the airborne or droplet transmission of cystic fibrosis (CF) infection. A study published in the November 2008 issue of "Thorax," showed that patients diagnosed with CF could transmit Pseudomonas aeruginosa and other Gram-negative bacteria when they cough. Another study, by...

  • Biofilms, Antimicrobial Resistance, and Airway Infection. Prince, Alice S. // New England Journal of Medicine;10/3/2002, Vol. 347 Issue 14, p1110 

    Reports on drug efficacy in treatment of pulmonary infection in patients with cystic fibrosis. Treatments to eradicate the Pseudomonas aeruginosa bacteria not always effective; Discussion of bacterial communities called biofilms; Illustration depicting formation of biofilms; Limited efficacy of...


Read the Article


Sign out of this library

Other Topics